Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chaperonin containing TCP1 subunit 4 pseudogene 2 (CCT4P2) is a human pseudogene and does not encode a functional protein. It is related in sequence to the protein-coding gene CCT4, which is a bona fide subunit of the eukaryotic chaperonin-containing TCP1 (CCT/TRiC) complex, but CCT4P2 itself has no known protein product, no reported biological functions, no established involvement in disease, and is not a therapeutic target or receptor[1][2][5][7]. Clarifications: - CCT4P2 is classified as a pseudogene, and functional or disease associations, drug interactions, and roles typical of a protein-coding gene or a true receptor/enzyme do not apply. - The true protein-coding chaperonin-containing TCP1 subunit 4 (CCT4), in contrast, is a component of the TRiC/CCT molecular chaperone complex essential for folding cytoskeletal proteins, but CCT4P2 is only a noncoding, nonfunctional genetic element resembling this protein[1][3][5]. - There appear to be no drugs, mechanisms of action, biomarker uses, or safety concerns associated with CCT4P2, and it is not a correct or relevant therapeutic target. Summary: CCT4P2 is a pseudogene (a non-functional gene copy) and thus does not encode a protein, have therapeutic relevance, or serve as a drug target. Any functional information should be associated with the protein-coding gene CCT4, not CCT4P2[1][2][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chaperonin containing TCP1 subunit 4 pseudogene 2 (CCT4P2).